Dr. Reddy's Laboratories Limited (DRREDDY) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE089A01023
Key metrics
- Market Cap
- ₹96,210 Cr
- P/E Ratio
- 29.12
- EPS
- 39.67
- Book Value
- 455.82
- P/B Ratio
- 2.55
- ROE
- 11.26%
- ROCE
- 10.95%
- Debt / Equity
- 0.2
- Net Margin
- 12.76%
- Revenue Growth
- 3.19%
- Profit Growth
- -24.22%
- Dividend Yield
- 0.69%
- 52W High
- ₹1,414.90
- 52W Low
- ₹1,101.00
- Market Cap Band
- large cap
- Face Value
- 1
Ratios computed from the annual results period ending 2026-03-31.
About Dr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. Its Others segment engages in developing therapies in the fields of oncology and inflammation; and research, development, and commercialization of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines, vitamins and minerals, and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
- Headquarters
- Hyderabad, India
- Employees
- 27,527
- Promoter Holding
- 30.13%
The full Dr. Reddy's Laboratories Limited analysis
Create a free account to open the complete DRREDDY deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.